|
⚲
|
| Neurotherapeutics Pharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001385386 |
| Sale | 2008-12-22 ($5.8 M Offered, $3.2 M Sold) |
| Fund | |
| Phone | 7734444180 |
| Address | 8420 W Byrn Mawr Avenue Chicago, 60631 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Brian Williams | |
| Phillip Morgan PhD | |
| Karen Boezi | |
| Holli Carlson | |
| Stephen Wanaski PhD | |
| Stephen Collins Md PhD | |
| Heath Lukatch PhD |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Credit Value Fund III, LP
✚
|
0.0 | |
|
CRE Fund II, a series of Hack VC, LP
✚
|
0.0 | |
|
LSREF V Investments, L.P.
✚
|
0.0 | |
|
LSV Special Opportunities Domestic Fund V, L.P.
✚
|
0.0 | |
|
LTMR C LP
✚
|
0.0 | |
|
Anchorage Capital Europe LLP
✚
|
0.0 | |
|
Anchorage Capital Group Australia PTY Ltd
✚
|
0.0 | |
|
Antero Resources LLC
✚
|
0.0 | |
|
Anthony Laura E
✚
|
0.0 | |
|
Creditera, Inc.
✚
|
0.0 |